Bispecific Antibodies
Antibodies engineered to bind two targets simultaneously, often a tumor antigen and CD3 to engage T cells. Examples: blinatumomab, teclistamab, talquetamab.
No Treatments found for this treatment modalitie.
Antibodies engineered to bind two targets simultaneously, often a tumor antigen and CD3 to engage T cells. Examples: blinatumomab, teclistamab, talquetamab.
No Treatments found for this treatment modalitie.